Psoriasis and type 2 diabetes risk among psoriatic patients in a Spanish population

被引:21
作者
Armesto, Susana [1 ]
Santos-Juanes, Jorge [2 ]
Galache-Osuna, Cristina [2 ]
Martinez-Camblor, Pablo [3 ]
Coto, Eliecer [4 ]
Coto-Segura, Pablo [2 ]
机构
[1] Hosp Marques Valdecilla, Dermatol Unit, Santander, Spain
[2] Hosp Cent Univ Hosp Asturias HUCA, Dept Dermatol 2, Oviedo, Spain
[3] Hosp Cent Univ Hosp Asturias HUCA, Dept Math, Oviedo, Spain
[4] Hosp Cent Univ Hosp Asturias HUCA, Mol Genet Dept, Oviedo, Spain
关键词
diabetes mellitus; psoriasis; INSULIN-RESISTANCE; ATHEROSCLEROSIS; INFLAMMATION; ASSOCIATION; DISEASE;
D O I
10.1111/j.1440-0960.2011.00802.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
There is accumulating evidence showing a relationship between psoriasis and an increased risk of developing cardiovascular risk factors, including diabetes mellitus type 2 and ischemic heart disease. Our aim was to investigate if there is any difference in the diabetes risk profile among psoriatic patients based on clinical findings. To test this, we carried out a prospective and descriptive hospital-based study. Our results suggest that the highest risk of suffering from diabetes mellitus type 2 among psoriatic patients is in patients suffering from non-familial and late-onset disease and in patients suffering from psoriatic arthritis.
引用
收藏
页码:128 / 130
页数:3
相关论文
共 21 条
[1]
Psoriasis and hypertension: a case-control study [J].
Armesto, S. ;
Coto-Segura, P. ;
Osuna, C. G. ;
Camblor, P. M. ;
Santos-Juanes, J. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (06) :785-788
[2]
STATISTICAL ASSOCIATION BETWEEN PSORIASIS AND DIABETES - FURTHER RESULTS [J].
BINAZZI, M ;
CALANDRA, P ;
LISI, P .
ARCHIV FUR DERMATOLOGISCHE FORSCHUNG, 1975, 254 (01) :43-48
[3]
Psoriasis patients show signs of insulin resistance [J].
Boehncke, S. ;
Thaci, D. ;
Beschmann, H. ;
Ludwig, R. J. ;
Ackermann, H. ;
Badenhoop, K. ;
Boehncke, W-H. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (06) :1249-1251
[4]
Psoriasis - epidemiology and clinical spectrum [J].
Christophers, E .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2001, 26 (04) :314-320
[5]
Psoriasis and diabetes: a population-based cross-sectional study [J].
Cohen, A. D. ;
Dreiher, J. ;
Shapiro, Y. ;
Vidavsky, L. ;
Vardy, D. A. ;
Davidovici, B. ;
Meyerovitch, J. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2008, 22 (05) :585-589
[6]
Risk of type 2 diabetes attributable to C-reactlve protein and other risk factors [J].
Dehghan, Abbas ;
van Hoek, Mandy ;
Sijbrands, Eric J. G. ;
Stijnen, Theo ;
Hofman, Albert ;
Witteman, Jacqueline C. M. .
DIABETES CARE, 2007, 30 (10) :2695-2699
[7]
Low-grade systemic inflammation and the development of type 2 diabetes - The atherosclerosis risk in communities study [J].
Duncan, BB ;
Schmidt, MI ;
Pankow, JS ;
Ballantyne, CM ;
Couper, D ;
Vigo, A ;
Hoogeveen, R ;
Folsom, AR ;
Heiss, G .
DIABETES, 2003, 52 (07) :1799-1805
[8]
What characterizes the severity of psoriasis? [J].
Garcia-Diez, Amaro ;
Foraster, Carlos Ferrandiz ;
Sebastian, Francisco Vanaclocha ;
Tudela, Luis Lizan ;
Llach, Xavier Badia ;
Fernandez, Guillermo Sellers .
DERMATOLOGY, 2008, 216 (02) :137-151
[9]
SYSTEMIC ABSORPTION OF TOPICAL STEROIDS - METABOLIC EFFECTS AS AN INDEX OF MILD HYPERCORTISOLISM [J].
GARDEN, JM ;
FREINKEL, RK .
ARCHIVES OF DERMATOLOGY, 1986, 122 (09) :1007-1010
[10]
Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1734